🔗 Share this article

This year's prestigious award in Physiology or Medicine has been awarded for revolutionary findings that illuminate how the immune system attacks dangerous infections while protecting the body's own cells.

Three renowned researchers—from Japan Prof. Sakaguchi and American scientists Mary Brunkow and Dr. Ramsdell—share this accolade.

The research uncovered specialized "sentinels" within the immune system that remove malfunctioning immune cells that could attacking the body.

The discoveries are now enabling innovative treatments for immune disorders and malignancies.

The winners will share a prize fund valued at 11 million SEK.

Crucial Findings

"The research has been essential for comprehending how the body's defenses functions and why we don't all suffer from severe autoimmune diseases," stated the chair of the award panel.

The team's studies explain a fundamental mystery: How does the defense system protect us from numerous invaders while leaving our healthy cells unharmed?

The body's protection system uses immune cells that scan for signs of infection, including viruses and germs it has not met before.

Such defenders utilize detectors—called receptors—that are generated by chance in countless variations.

This gives the defense network the capacity to fight a broad range of invaders, but the randomness of the mechanism unavoidably produces immune cells that may attack the host.

Protectors of the Immune System

Scientists earlier understood that some of these problematic defense cells were destroyed in the thymus—the site where white blood cells mature.

The latest Nobel Prize honors the identification of regulatory T-cells—described as the body's "peacekeepers"—which patrol the body to disarm other defenders that assault the body's own tissues.

We know that this process malfunctions in autoimmune diseases such as type-1 diabetes, MS, and RA.

The Nobel panel stated, "These discoveries have established a new field of investigation and spurred the development of innovative therapies, for instance for tumors and autoimmune diseases."

In malignancies, T-regs prevent the body from fighting the growth, so studies are focused on reducing their quantity.

For autoimmune diseases, experiments are testing increasing regulatory T-cells so the organism is no longer under attack. A similar method could also be effective in minimizing the risks of transplanted organ rejection.

Innovative Experiments

Prof Shimon Sakaguchi, of a Japanese institution, conducted experiments on rodents that had their immune gland removed, causing self-attack conditions.

The researcher showed that introducing defense cells from healthy mice could stop the disease—implying there was a system for blocking defenders from attacking the host.

Mary Brunkow, from the Institute for Systems Biology in Seattle, and Dr. Ramsdell, currently at a biotech firm in a California city, were investigating an genetic immune disorder in mice and humans that resulted in the identification of a genetic factor vital for how T-regs operate.

"Their groundbreaking work has revealed how the body's defenses is kept in check by T-reg cells, preventing it from accidentally attacking the healthy cells," commented a leading physiology expert.

"This work is a remarkable example of how fundamental biological research can have far-reaching implications for human health."